Travel Medicine and Infectious Disease
Volume 8, Issue 4 , Pages 210-212, July 2010

Linking yellow fever vaccinator approval and renewal with training in travel medicine in New Zealand☆

  • Brigid O’Brien

      Affiliations

    • Auckland Regional Public Health Service, Auckland, New Zealand
    • ,
  • Peter A. Leggat

      Affiliations

    • School of Public Health, Tropical Medicine and Rehabilitation Sciences, James Cook University, Townsville, Queensland 4811, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 7 47816108; fax: +61 7 47815254.

Received 15 May 2010; accepted 20 May 2010. published online 17 June 2010.

Summary 

Yellow fever is a mosquito-borne disease, which can cause serious illness. The World Health Organization (WHO) requires travellers to have vaccination against Yellow fever for all international travel going into and from Yellow fever endemic areas in order to prevent the spread of this potentially deadly disease. Only clinics and hospitals authorised by health departments of national governments can administer the disease. Yellow fever vaccination centres are often subject to inspection in many countries, although the requirements for Yellow fever vaccinators (YFV) vary from country to country. In New Zealand, approval of YFV now requires specific postgraduate training in travel medicine or its equivalent, as well as continuing professional development to maintain this status. It is expected that this will assist in improving standards of travel medicine practice in New Zealand.

Keywords: Yellow fever, Vaccination, Vaccinators, New Zealand, International health regulations

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

☆ The authors do not necessary represent the views of the New Zealand Government, the New Zealand Ministry of Health or of any other organisation referred to in this paper.

PII: S1477-8939(10)00094-3

doi:10.1016/j.tmaid.2010.05.008

Travel Medicine and Infectious Disease
Volume 8, Issue 4 , Pages 210-212, July 2010

Article Tools